Should ¹⁸F-FDG-PET imaging be used in the diagnosis of GCA?

Nat Rev Rheumatol. 2019 Jul;15(7):388-390. doi: 10.1038/s41584-019-0236-4.

Authors

Dario Camellino^{1

2}, Christian Dejaco^{3

4}

Affiliations

¹ Division of Rheumatology, La Colletta Hospital, Arenzano, Italy.
² Autoimmunology Laboratory, University of Genoa, Genoa, Italy.
³ Rheumatology Service, South Tyrol Health Trust, Bruneck, Italy. christian.dejaco@gmx.net.
⁴ Department of Rheumatology, Medical University Graz, Graz, Austria. christian.dejaco@gmx.net.

PMID: 31073217
DOI: 10.1038/s41584-019-0236-4

No abstract available

Publication types

Comment

MeSH terms

Cross-Sectional Studies
Double-Blind Method
Fluorodeoxyglucose F18*
Giant Cell Arteritis*
Humans
Multimodal Imaging
Positron-Emission Tomography
Prospective Studies

Substances

Fluorodeoxyglucose F18